PegIFN-α2a for the treatment of chronic hepatitis B and C: a 10-year history - Degasperi, Elisabetta; Viganò, Mauro; Aghemo, Alessio; Lampertico, Pietro; Colombo, Massimo (Expert review of anti-infective therapy, 2013)
Keywords: Antiviral Agents - therapeutic use; antiviral therapy; boceprevir; DNA, Viral - antagonists & inhibitors; Drug Administration Schedule; Drug Therapy, Combination; HBV; HCV; Hepacivirus - drug effects; Hepacivirus - physiology; Hepatitis B Surface Antigens - blood; Hepatitis B virus - drug effects; Hepatitis B virus - physiology; Hepatitis B, Chronic - drug therapy; Hepatitis B, Chronic - immunology; Hepatitis B, Chronic - virology; Hepatitis C, Chronic - drug therapy; Hepatitis C, Chronic - immunology; Hepatitis C, Chronic - virology; Humans; Interferon-alpha - therapeutic use; nucleos(t)ide analogs; PegIFN-α2a; Polyethylene Glycols - therapeutic use; Recombinant Proteins - therapeutic use; Ribavirin - therapeutic use; telaprevir; Treatment Outcome; Viral Load - drug effects